Volume 19, Issue 2

Devika Radhakrishnan, Renee Lynn Rego, Sanjana S, Wilsita Snehal D’Souza, Cyril Tom

pp. 297–303 · DOI: 10.5530/ijopp.20260586 · 2025

Aim: This research aims to evaluate how clinical pharmacy interventions affect patient outcomes, focusing on areas like patient counseling and pain management.Materials and Methods:This six-month prospective observationa…

Swaraj Tawale, Nadim Khan, Radhika Shinde, Mangesh Thote, Amol Joshi

pp. 304–310 · DOI: 10.5530/ijopp.20260551 · 2025

Background: While working with patients on hemodialysis, we often heard them complain about restless nights. Some couldn’t fall asleep, others woke up too early, and many felt drained during the day. These weren’t just o…

Ancy A, Kavyasree K, Philip Finny, Shone Padinjarethil George

pp. 323–325 · DOI: 10.5530/ijopp.20260599 · 2025

Nivolumab, an immune checkpoint inhibitor, has revolutionized the treatment of various malignancies, including esophageal adenocarcinoma. However, its use is associated with immune-related Adverse Events (irAEs), includi…

Vijay Ram, Karthikesan Jayasri, Gurumurthy Haripriya, Aadalarasan Jeeva

pp. 311–316 · DOI: 10.5530/ijopp.20260468 · 2025

Dexamethasone is a potent synthetic glucocorticoid widely prescribed for its anti-inflammatory and immunosuppressive effects. However, long-term unsupervised use may lead to serious endocrine and infectious complications…

Damini Kharb, Muskan Kumari, Parshant Pokhriyal, Amarnath Pandey, Anuj Nautiyal

pp. 317–322 · DOI: 10.5530/ijopp.20260461 · 2025

Human Metapneumovirus (HMPV) is a significant viral pathogen known to cause severe respiratory infections, including pneumonia, Acute Respiratory Distress Syndrome (ARDS), and type-1 respiratory failure in adults. Early …